CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23, ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best biotech stocks to buy. Following CRISPR Therapeutics AG ...

Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.

CRISPR Therapeutics (CRSP) just announced that its SyNTase gene editing technology will be featured in an oral presentation at the ESGCT 2025 Congress. This marks the first major public unveiling of ...

The University of Chicago will sell one of its valuable research centers for $375 million as it attempts to cope with various ...

CRISPR Therapeutics AG (CRSP) ended the recent trading session at $67.74, demonstrating a -6.98% change from the preceding day's closing price. This change lagged the S&P 500's 0.01% gain on the day.

The University of Chicago is selling its Center for Research in Security Prices to the investment firm Morningstar for $375 million. The CRSP was created at what is now the U of C's Booth School of ...

Morningstar Inc. (NASDAQ:MORN) is one of the best buy-the-dip stocks to buy, according to analysts. On September 23, the ...

The university is selling off the Center for Research in Security Prices as it cuts staff and battles a $288 million deficit.

The CRSP was created at what is now the U of C’s Booth School of Business more than 65 years ago. It provides historical ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

The biotech industry is almost always buzzing. However, there has been some unanticipated activity in this sector of late.